<DOC>
	<DOCNO>NCT02171962</DOCNO>
	<brief_summary>The objective study evaluate Zilver® PTX® Drug-Eluting Peripheral Stent treatment lesion above-the-knee femoropopliteal artery Chinese patient population .</brief_summary>
	<brief_title>Zilver® PTX® China</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Symptoms peripheral arterial disease correspond Rutherford Classification 24 Stenotic ( &gt; 50 % diameter stenosis ) occlude lesion abovethe knee femoropopliteal artery Reference vessel diameter 49 mm Lesion length 140 mm Unsuccessful arterial interventional treatment leg within 30 day prior study procedure Previous stent study vessel Bypass graft anastomosis study vessel Significant stenosis occlusion inflow tract successfully treat prior treating study lesion No patent vessel runoff</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Zilver® PTX® Drug-Eluting Peripheral Stent</keyword>
	<keyword>Above-the-Knee Femoropopliteal Artery</keyword>
	<keyword>Chinese patient</keyword>
</DOC>